单中心16年青年膀胱尿路上皮癌患者的诊治

doi:10.3969/j.issn.1671-167X.2018.04.010

摘要/Abstract

摘要： 目的：研究40岁及以下青年膀胱尿路上皮癌患者的临床表现、临床分期、病理分级、治疗及预后等情况。方法：选择 2001年1月至2016年12月北京大学第三医院泌尿外科收治的43例40岁及以下的膀胱癌患者临床资料进行回顾性分析。结果：本组病例占同期科室收治的膀胱癌患者的2.2%，男性35例，女性8例，平均年龄33岁（23~40岁）。初诊时以无痛性肉眼血尿为主要症状者27例（62.8%），体检发现异常者9例（20.9%），以膀胱刺激症状或排尿异常起病者7例（16.3%）。肿瘤单发者34例（79.1%），多发者9例（20.9%）,且多发者均在31~40岁亚组。根据患者临床分期采用相应的手术方式治疗。术后病理分级：低级别乳头状尿路上皮癌29例（67.4%），高级别乳头状尿路上皮癌14例（32.6%）。Ta期31例（72.1%），T1期7例（16.3%）， T3期1例（2.3%）， T4期3例（7.0%），T1期合并Tis 1例（2.3%）。术后3例失访，另40例随访5~165个月，随访患者中有5例复发，复发率12.5%（5/40），平均复发时间39个月（3~105个月）， 2例患者进展，进展率5%（2/40）。多发患者组复发率33%（3/9），单发患者组复发率5.9%（2/34），两组差异具有统计学意义（P=0.000 3）。结论：青年膀胱癌的发病比例呈增长趋势，无痛性肉眼血尿是青年膀胱癌的主要临床表现，但青年患者的下尿路刺激症状同样需警惕肿瘤的发生，术后的复发情况可能与多发病变有关。

关键词: , 膀胱癌, 青年, 预后

Abstract: Objective： To evaluate the clinical and pathological features, treatment and prognosis for bladder urothelial carcinoma in relative young patients under 40 years. Methods: A retrospective study involved a total of 43 consecutive patients of bladder urothelial carcinoma, which were under 40 years old from January 2001 to December 2016. Results: The incidence rate of bladder urothelial carcinoma in the patients under 40 years was 2.2%, and 35 males and 8 females were included. The average age was 33 years (ranging from 23 to 40 years). At initial visit, 62.8% of the patients presented with painless gross hematuria, 9 patients were discovered by routine examination, and 7 patients experienced lower urinary tract symptoms. Solitary tumor occurred in 34 cases whereas multiple carcinomas had been discovered in 9 cases，and all the 9 multiple cases were from 31-40-year-old subgroups. All the patients received proper surgical intervention according to their own clinical stages. Post-operative pathological results showed 29 low-grade urothelial carcinoma and 14 high-grade cases which included 31 Ta cases, with 7 cases of T1, 1 case of T3, and 3 cases of T4 and one case of T1 plus Tis. The total follow-up was from 5 to 165 months,3 cases were lost. The overall recurrence rate was 12.5% (5 cases from 40). One patient developed distal metastasis, one died of metastasis after 13 months, and the other three received secondary trans-urethral resection of bladder tumors. The average recurrence time was 39 months (rang-ing from 3 to 105 months). The progression rate was 5% among all the followedup patients (2 cases from 40). The recurrence rate in multiple lesions group (33%, 3/9) was significantly higher than that (5.9%, 2/34) in solitary lesion group (P=0.000 3). Conclusion: The incidence rate of bladder urothelial carcinoma in young patients under 40 years becomes increasingly higher over years. The major initial presentation is painless gross hematuria among these young patients, but lower urinary tract symptoms should also be noticed for young patients to rule out tumor. Postoperative tumor recurrence might be associated with multiple lesions, which is not related to the tumor size or pathological features.

Key words: Bladder urothelial carcinoma, Young, Prognosis

中图分类号:

R694

唐兴国，颜野，邱敏，卢剑，陆敏，侯小飞，黄毅，马潞林. 单中心16年青年膀胱尿路上皮癌患者的诊治[J]. 北京大学学报(医学版), 2018, 50(4): 630-633.

TANG Xing-guo, YAN Ye, QIU Min, LU Jian, LU Min, HOU Xiao-fei, HUANG Yi, MA Lu-lin. Retrospective study of young bladder urothelial carcinoma from a single center within 16 years[J]. Journal of Peking University(Health Sciences), 2018, 50(4): 630-633.

参考文献

相关文章 15

[1]	王飞,朱翔,贺蓓,朱红,沈宁. 自发缓解的滤泡性细支气管炎伴非特异性间质性肺炎1例报道并文献复习[J]. 北京大学学报（医学版）, 2021, 53(6): 1196-1200.
[2]	高伟波,石茂静,张海燕,吴春波,朱继红. 显著高铁蛋白血症与噬血细胞性淋巴组织细胞增多症的相互关系[J]. 北京大学学报（医学版）, 2021, 53(5): 921-927.
[3]	张梅香,史文芝,刘建新,王春键,李燕,王蔚,江滨. MLL-AF6融合基因阳性急性髓系白血病的临床特征及预后[J]. 北京大学学报（医学版）, 2021, 53(5): 915-920.
[4]	蒋艳芳,王健,王永健,刘佳,裴殷,刘晓鹏,敖英芳,马勇. 前交叉韧带翻修重建术后中长期临床疗效及影响因素[J]. 北京大学学报（医学版）, 2021, 53(5): 857-863.
[5]	肖若陶,刘承,徐楚潇,何为,马潞林. 术前血小板参数与局部进展期肾细胞癌预后[J]. 北京大学学报（医学版）, 2021, 53(4): 647-652.
[6]	于妍斐,何世明,吴宇财,熊盛炜,沈棋,李妍妍,杨风,何群,李学松. 延胡索酸水合酶缺陷型肾细胞癌的临床病理特征及预后[J]. 北京大学学报（医学版）, 2021, 53(4): 640-646.
[7]	赵勋,颜野,黄晓娟,董靖晗,刘茁,张洪宪,刘承,马潞林. 癌栓粘连血管壁对非转移性肾细胞癌合并下腔静脉癌栓患者手术及预后的影响[J]. 北京大学学报（医学版）, 2021, 53(4): 665-670.
[8]	陈怀安,刘硕,李秀君,王哲,张潮,李凤岐,苗文隆. 炎症生物标志物对输尿管尿路上皮癌患者预后预测的临床价值[J]. 北京大学学报（医学版）, 2021, 53(2): 302-307.
[9]	刘世博,高辉,冯元春,李静,张彤,万利,刘燕鹰,李胜光,罗成华,张学武. 腹膜后纤维化致肾盂积水的临床分析:附17例报道[J]. 北京大学学报（医学版）, 2020, 52(6): 1069-1074.
[10]	陈伟钱,戴小娜,余叶,王沁,梁钧昱,柯旖旎,易彩虹,林进. 原发性干燥综合征合并自身免疫性肝病的临床特点及预后分析[J]. 北京大学学报（医学版）, 2020, 52(5): 886-891.
[11]	姜妮,乔国梁,王小利,周心娜,周蕾,宋雨光,赵艳杰,任军. 中性粒细胞与淋巴细胞比例对评估接受过继性细胞免疫治疗的晚期胰腺癌患者预后的临床意义[J]. 北京大学学报（医学版）, 2020, 52(3): 597-602.
[12]	马茹,李鑫宝,闫风彩,林育林,李雁. 肿瘤间质比评估阑尾来源腹膜假黏液瘤的临床价值[J]. 北京大学学报（医学版）, 2020, 52(2): 240-246.
[13]	王文鹏,王捷夫,胡均,王俊锋,刘嘉,孔大陆,李健. 结直肠间质瘤临床病理特征及预后分析[J]. 北京大学学报（医学版）, 2020, 52(2): 353-361.
[14]	王骁,李兆星,范焕芳,魏莉瑛,郭旭瑾,郭娜,王彤. 罕见小肠囊腺瘤1例报道[J]. 北京大学学报（医学版）, 2020, 52(2): 382-384.
[15]	欧阳雨晴,倪莲芳,刘新民. 恶性孤立性肺结节患者预后因素分析[J]. 北京大学学报（医学版）, 2020, 52(1): 158-162.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed